NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 75 filers reported holding NOVELION THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,000 | – | 2,680 | +192.3% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 917 | -40.6% | 0.00% | – |
| Q1 2019 | $2,000 | -33.3% | 1,544 | -45.6% | 0.00% | – |
| Q4 2018 | $3,000 | -99.9% | 2,839 | -99.8% | 0.00% | -100.0% |
| Q3 2018 | $4,826,000 | -18.7% | 1,630,470 | +1.1% | 0.00% | -50.0% |
| Q2 2018 | $5,937,000 | +5.4% | 1,613,210 | +0.2% | 0.00% | 0.0% |
| Q1 2018 | $5,635,000 | +51.5% | 1,610,178 | +35.1% | 0.00% | +100.0% |
| Q4 2017 | $3,719,000 | -52.8% | 1,191,978 | +6.3% | 0.00% | -50.0% |
| Q3 2017 | $7,884,000 | +64.9% | 1,121,508 | +116.5% | 0.00% | +100.0% |
| Q2 2017 | $4,782,000 | +295.9% | 518,117 | +360.3% | 0.00% | – |
| Q1 2017 | $1,208,000 | +4546.2% | 112,572 | +3547.8% | 0.00% | – |
| Q4 2016 | $26,000 | – | 3,086 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|